Belgium· BE-AMP-SAM344522-00
Iressa 250 mg
A gefitinib product containing gefitinib, registered in Belgium by AstraZeneca. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Gefitinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EB01 (gefitinib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Gefitinib · ATC L01EB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gefitinib costs, country by country.
Normalised to the WHO defined daily dose (0.25 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gefitinib · price per daily dose (0.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$95.15
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Gefitinib
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- L01EB01
- ATC class
- Gefitinib
- Defined daily dose
- 0.25 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0797712
- be_apb2616993
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
414 interactions on record for gefitinib.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gefitinib · interactions on record
414 records
- 11 severe
- 193 moderate
- 5 minor
- 205 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gefitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGEFITINIB ACCORD 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FranceGEFITINIB ACCORD 250 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- NetherlandsGefitinib Eugia 250 mg filmomhulde tablettenEugia Pharma (Malta) Limited
- FinlandGefitinib AccordAccord Healthcare B.V.
- PolandGefitinib AccordAccord Healthcare Polska Sp. z o.o.
- SwedenGefitinib Accord 250 mg Filmdragerad tablettAccord Healthcare B.V.
- United StatesGefitinibTeva Pharmaceuticals, Inc.
- IcelandGefitinib STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Gefitinib Accord
- Bulgaria · Фромпо
- Cyprus · Refetib
- Czechia · Gefitinib Accord
- Germany · Gefitinib Accord, Gefitinib Genthon
- Denmark · Gefitinib Accord, Gefitinib Stada
- Estonia · Gefitinib Auxilia, Gefitinib Norameda
- Spain · Gefitinib Efg Genthon, Gefitinib Eugia
- Finland · Gefitinib Accord, Gefitinib Stada
- France · Gefitinib Arrow, Gefitinib Biogaran
- United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
- Greece · Gefitinib Faran, Gefitinib Genepharm
- Croatia · Gefitinib Pliva, Gefitinib Sandoz
- Hungary · Gefitinib Genepharm, Gefitinib Onkogen
- Iceland · Gefitinib Stada, Gefitinib Wh
- Italy · Gefitinib Medac
- Liechtenstein · Iressa
- Lithuania · Gefitinib Norameda
- Latvia · Gefitinib Norameda
- Malta · Gefitinib Eugia, Gefitinib Genthon
- Netherlands · Gefitinib Eugia, Gefitinib Genthon
- Norway · Gefitinib Stada, Iressa
- Poland · Gefitinib Accord, Gefitinib Genthon
- Portugal · Gefitinib Accord, Gefitinib Eugia
- Romania · Gefitinib Accord, Gefitinib Polisano
- Sweden · Gefitinib Accord, Gefitinib Stada
- Slovenia · Phrompo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbb6686e-b6d5-4b3a-8e53-762124c2b1fc GET /v1/drugs/cbb6686e-b6d5-4b3a-8e53-762124c2b1fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Iressa 250 mg",
"name_fr": "Iressa 250 mg",
"name_nl": "Iressa 250 mg",
"amp_code": "SAM344522-00",
"strengths": [
"250.0000",
"250.0000"
],
"pack_count": 2,
"substances": [
"Gefitinib",
"Lactose Monohydrate",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Gefitinib",
"authorisation_numbers": [
"EU/1/09/526/001",
"EU/1/09/526/002"
]
}See everything about gefitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.